Time-lapse images of HL-60 cells treated with 0.5 micromolar DAC and ceralasertib
Description
Time-lapse images of HL-60 cells treated with 0.5 micromolar Decitabine and the ATR-selective inhibitor ceralasertib. DNA was labeled with siR-DNA. Channel1; siR-DNA, Channel2; bright field
Yabushita T, Chinen T, Nishiyama A, Asada S, Shimura R, Isobe T, Yamamoto K, Sato N, Enomoto Y, Tanaka Y, Fukuyama T, Satoh H, Kato K, Saitoh K, Ishikawa T, Soga T, Nannya Y, Fukagawa T, Nakanishi M, Kitagawa D, Kitamura T, Goyama S. Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment. Cell Rep. 2023 Sep 26;42(9):113098.
Related paper(s)
Contact
Susumu Goyama
, The University of Tokyo
, Division of Molecular Oncology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences
, Division of Molecular Oncology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences